Anavex Life Sciences AVXL
NASDAQ AVXL
$1.06 -0.07 (-6.19%)
At close: Nov 11, 2026 · 4:00 PM EST

Anavex Life Sciences (AVXL) Other Operating Expenses (2009 - 2026)

Updated

Anavex Life Sciences (AVXL) recorded Other Operating Expenses of -$2.03 million in fiscal Q3 2026 (quarter ended Jun 30, 2026).

Analysis

Anavex Life Sciences (AVXL) Other Operating Expenses (2009 - 2026) Analysis & Trends

For FY2020 (ended Sep 30, 2020), Anavex Life Sciences reported Other Operating Expenses of -$62.18 million.

  • The fiscal Q3 2026 figure is the lowest quarterly Other Operating Expenses since fiscal Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Anavex Life Sciences 104.75 Mn -375.33 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.06 Mn
Dec 31, 2014 -318.31 Mn
Jun 30, 2014 -264.75 Mn
Mar 31, 2014 -118.03 Mn
Dec 31, 2013 772,874.00
Sep 30, 2013 14,135.00
Jun 30, 2013 5,373.00
Mar 31, 2013 187.00
Sep 30, 2012 741,155.00
Jun 30, 2012 4,464.00
Mar 31, 2012 31,200.00
Dec 31, 2011 23,163.00
Sep 30, 2011 70,644.00
Jun 30, 2011 59,864.00
Mar 31, 2011 20,026.00
Dec 31, 2010 31,725.00
Sep 30, 2010 234,576.00
Jun 30, 2010 1,692.00
Mar 31, 2010 13,116.00
Dec 31, 2009 81,037.00
API Access

Anavex Life Sciences Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=AVXL&period=max&api_key=YOUR_API_KEY